Time to stop routine prescription of low-molecular-weight heparin to women with recurrent pregnancy loss and inherited thrombophilia

Lancet. 2023 Jul 1;402(10395):6-7. doi: 10.1016/S0140-6736(23)01190-X.

Authors

Annika Strandell¹, Margareta Hellgren²

Affiliations

¹ Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden. Electronic address: annika.strandell@vgregion.se.
² Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg 413 45, Sweden.

PMID: 37393104
DOI: 10.1016/S0140-6736(23)01190-X

No abstract available

Publication types

Comment

MeSH terms

Abortion, Habitual* / prevention & control
Female
Heparin, Low-Molecular-Weight / therapeutic use
Humans
Pregnancy
Thrombophilia* / complications
Thrombophilia* / drug therapy

Substances

Heparin, Low-Molecular-Weight

Supplementary concepts

Thrombophilia, hereditary